Central Nervous Processing of Visual Food Stimuli in Severely Obese Subjects
2 other identifiers
observational
38
1 country
1
Brief Summary
Recent evidence has pointed to distinct alterations of brain functions in obese subjects some of which may even be causative for their obesity. The objective of this study was to examine food and non food related alterations in brain functions after excessive weight loss due to Roux-en Y gastric bypass surgery (RYGB), one of the most successful therapeutic approaches for long lasting weight loss. The investigators hypothesized that obese as compared with lean women show an altered activation pattern in the brain areas involved in the homeostatic regulation of eating behavior, i.e. the hypothalamus, in reward-related brain areas, such as the orbital frontal cortex (OFC) and the striatum as well as in prefrontal inhibitory control areas. Furthermore, the investigators hypothesized that women who had undergone a RYGB operation show a brain activity pattern that more closely mimics that of lean than severely obese women. In a supplementary test the investigators will assess gastrointestinal and metabolic response to a standardized meal in order to elucidate putative correlation of these responses with the results of fMRI scannings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 2, 2011
CompletedFirst Posted
Study publicly available on registry
December 16, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMarch 12, 2025
March 1, 2013
3.3 years
December 2, 2011
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
brain activity
In all women brain activity was assessed by functional magnetic resonance imaging (fMRI, BOLD Method, 1.5 Tesla fMRI Scanner, Siemens, Erlangen, Germany) during the presentation of food and non-food related pictures as well as during state conditions. In all three groups, brain activity was measured at a single time point. Of note, women, who had undergone Roux-en Y gastric bypass surgery were measured between 13 and 106 month after surgery. Brain activity was not measured before surgery in this group.
brain activity was measured at a single time point in all three groups; of note: women after Roux-en Y gastric bypass surgery were measured between 13 and 106 month after surgery.
Secondary Outcomes (1)
gastrointestinal and metabolic responses to standardized meal
measured at a single time point in all three groups; of note: women after Roux-en Y gastric bypass surgery were measured between 13 and 106 month after surgery at a single time point
Study Arms (3)
severely obese women
Women after Roux-en Y gastric bypass surgery
Women recruited for this group had undergone Roux-en Y gastric bypass surgery at least one year before. In this women measurement of brain activity and gastrointestinal and metabolic response took place between 13 and 106 month after surgery.
lean women
Eligibility Criteria
Severely obese (body mass index; BMI \> 35 kg/m2) women and previously severely obese women who had undergone a Roux-en Y gastric bypass operation were recruited from the Interdisciplinary Obesity Center, cantonal hospital St. Gallen (Switzerland), and the adiposity platform of the University of Tübingen. lean control women were recruited in St. Gallen and in Tübingen
You may qualify if:
- women with BMI \> 35kg/m2
- women, who had undergone gastric bypass surgery at least one year ago
- lean women
You may not qualify if:
- known psychiatric or neurological diseases
- current medication with drug acting on the central nervous system
- drugs that are known to affect eating behavior
- contraindication for the fMRI scanning, e.g. metal implants or metal containing tattoos
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Interdisciplinary Obesity Center, Cantonal Hospital St. Gallen
Rorschach, 9400, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bernd Schultes, Prof. Dr. med.
Interdisciplinary Obesity Center, Kantonal Hospital St. Gallen, Rorschach, Switzerland
- PRINCIPAL INVESTIGATOR
Niels Birbaumer, Prof. Dr.
Institute of Medical Psychology and Behavioural Neurobiology, University of Tübingen, Tübingen, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med.
Study Record Dates
First Submitted
December 2, 2011
First Posted
December 16, 2011
Study Start
September 1, 2009
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
March 12, 2025
Record last verified: 2013-03